DCF — FRANCISCAN HEALTH HAMMOND
Enterprise Value: $-92.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-92.5M
Enterprise Value
$-31.4M
PV of Cash Flows
$-61.1M
PV of Terminal Value
$-98.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $121.2M | $-4.6M | -4.0% | $-9.7M | $-8.8M |
| Year 2 | $124.8M | $-3.5M | -3.0% | $-8.8M | $-7.3M |
| Year 3 | $128.6M | $-2.3M | -2.0% | $-7.8M | $-5.8M |
| Year 4 | $132.4M | $-1.7M | -1.0% | $-7.3M | $-5.0M |
| Year 5 | $136.4M | $-1.4M | -1.0% | $-7.2M | $-4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-92.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$117.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04297202619540721
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5